Related Experiment Video
Updated: Jun 29, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Symptomatic relapse of group A beta-hemolytic streptococcal tonsillopharyngitis in children
Janet R Casey1, Michael E Pichichero
1University of Rochester School of Medicine, Elmwood Pediatric Group, Rochester, New York, USA. jrcasey@rochester.rr.com
Insights
Antibiotic choice impacts relapse rates for group A streptococcal tonsillopharyngitis in children. Penicillin and amoxicillin showed higher failure rates compared to cephalosporins, necessitating careful drug selection for effective treatment.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Group A beta-hemolytic streptococcal tonsillopharyngitis is a common childhood infection.
- Antibiotic therapy is the standard treatment, but treatment failures and relapses can occur.
Purpose of the Study:
- To evaluate the frequency of symptomatic relapses after different antibiotic treatments for group A streptococcal tonsillopharyngitis in pediatric patients.
- To compare the effectiveness of various antibiotic classes in preventing relapses.
Main Methods:
- A study involving 1080 pediatric patients diagnosed with group A beta-hemolytic streptococcal tonsillopharyngitis.
- Analysis of symptomatic relapse rates within 5 days of completing antibiotic therapy.
- Comparison of relapse frequencies across different antibiotic regimens.
Main Results:
- The rank-order frequency of treatment failures was highest for penicillin, followed by amoxicillin, then first-generation cephalosporins, and lastly beta-lactamase stable cephalosporins and amoxicillin-clavulanate (P = .005).
- Retreatment of symptomatic failures led to a higher rate of subsequent relapses with penicillin compared to cephalosporins (P = .02).
Conclusions:
- The choice of antibiotic significantly influences the rate of symptomatic failures and relapses in pediatric group A streptococcal tonsillopharyngitis.
- Penicillin and amoxicillin appear less effective in preventing relapses compared to certain cephalosporins.
- Clinicians must consider these differences when selecting antibiotic therapy to minimize treatment failures.
Abstract:
The frequency of symptomatic relapses following various antibiotic treatments for group A beta-hemolytic streptococcal tonsillopharyngitis was evaluated in 1080 pediatric patients. Within 5 days of completing therapy, the rank-order frequency of treatment failures was (1) penicillin, (2) amoxicillin, (3) first-generation cephalosporins, (4) beta-lactamase stable cephalosporins and amoxicillin-clavulanate ( P = .005). Retreatment of symptomatic failures resulted in another symptomatic relapse more often with penicillin than with cephalosporins (P = .02). Clinicians should be aware that the rate of symptomatic failures after antibiotic therapy for group A beta-hemolytic streptococcal tonsillopharyngitis differs by drug and is not an uncommon event.
Related Concept Videos
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Tonsillitis II: Management
Rheumatic Heart Disease I: Introduction
Streptococcal Pharyngitis

